Table 1.
Demographic, clinical and laboratorial data of 75 patients with hip fracture
| Variables | 6 months mortality | P value | |
|---|---|---|---|
| No (n = 58) | Yes (n = 17) | ||
| Age (yrs.) | 78.4 ± 7.2 | 82.9 ± 8.9 | 0.04 |
| Female, % (no) | 72.4 (42) | 41.2 (7) | 0.04 |
| Hypertension, % (no) | 67.2 (39) | 58.8 (10) | 0.73 |
| Diabetes, % (no) | 22.4 (13) | 11.8 (2) | 0.50 |
| Smoking, % (n°) | 25.6 (20) | 35.3 (6) | 0.82 |
| Handgrip strength, (kgf) | 3.5 (0.0–5.8) | 0.0 (0.0–3.8) | 0.01 |
| Hemoglobin, (mg/dL) | 11.7 ± 2.3 | 11.3 ± 2.0 | 0.55 |
| CRP, (mg/dL) | 5.3 (3.7–8.2) | 8.8 (3.0–21.0) | 0.52 |
| Creatinine, (mg/dL) | 0.8 (0.7–1.1) | 1.1 (0.8–1.6) | 0.03 |
| Urea, (mg/dL) | 52.0 (35.8–68.0) | 81.5 (51.0–121.5) | 0.004 |
| Albumin, (g/L) | 3.2 (2.9–3.5) | 3.1 (2.5–3.4) | 0.41 |
| Sodium (mEq/L) | 139 (137–140) | 139 (135–141) | 0.79 |
| Potassium (mEq/L) | 4.1 (3.7–4.4) | 4.2 (4.0–4.9) | 0.09 |
| METs <4, % (n°) | 56.9 (33) | 82.4 (14) | 0.10 |
| TAS, (days) | 6.0 (4.0–8.0) | 4.0 (3.0–7.5) | 0.08 |
CRP C-reactive protein, METs metabolic equivalents, TAS time from admission to surgery. The data are expressed as the median (including the lower and upper quartiles), as mean ± standard deviation or as proportion